← Leaderboards
Ajjai Shivaram Alva
University Of Michigan At Ann Arbor
$1,551,379
Attributed
$3,102,758
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $653.3K · FY2019–24$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,102,758 · 1
By mechanism
U01$3,102,758 · 1
Top collaborators
- Lubomir M Hadjiyski6 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Chuan Zhou$5,071,831
- Lubomir M Hadjiyski$5,599,849
- Ryan William Stidham$3,043,991
- Phillip L Palmbos$2,630,125
- Joerg Lahann$3,367,884
Others in their field
Other Emerging Leaders on “Diagnosis”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
Research focus
DiagnosisEvaluationBench To BedsideAlternative TreatmentBladderEnsureCancer EtiologyCancer ImagingBiological MarkersCessation Of LifeCharacteristicsChemotherapyBladder NeoplasmClinical CareClinical Decision SupportClinical DevelopmentClinical Research SiteClinical TreatmentClinical TrialsCancer TypeComputersDecision Support SystemsDesignFeedback
Grant awards (6)
Biomarker-Based Tools for Treatment Response Decision Support of Bladder Cancer$501,952
U01 · FY2024 · CA
Biomarker-Based Tools for Treatment Response Decision Support of Bladder Cancer$84,236
U01 · FY2023 · CA
Biomarker-Based Tools for Treatment Response Decision Support of Bladder Cancer$612,655
U01 · FY2022 · CA
Biomarker-Based Tools for Treatment Response Decision Support of Bladder Cancer$625,260
U01 · FY2021 · CA
Biomarker-Based Tools for Treatment Response Decision Support of Bladder Cancer$625,336
U01 · FY2020 · CA
Biomarker-Based Tools for Treatment Response Decision Support of Bladder Cancer$653,319
U01 · FY2019 · CA